2024 has been another milestone year for the data center industry. Records were broken for mergers and acquisitions at the ...

The domestic startup ecosystem is expected to rebound with fresh approaches in key sectors like content, media, fintech, and ...

Federal Home Loan Mortgage Corporation (Freddie Mac) may see big gains with privatization. Find out why FMCC stock could be a ...

DraftKings, a powerhouse in the sports betting industry, has launched an enticing new service that enhances odds for parlay ...

Trump, a newly appointed advisor to GrabAGun, will become an equity holder once the transaction closes this summer. Although ...

This is an audio transcript of the FT News Briefing podcast episode: ‘Canadian politics post-Trudeau’ Kasia Broussalian Good morning from the Financial Times. Today is Wednesday, January 8th, and this ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.

After forming through the merger of three companies last summer, a Houston-based oil field services provider is going public.

Simpson Thacher partners offer IPO tips for private companies, noting that having an independent board and the correct ...

A New York appellate court on Tuesday denied President-elect Donald Trump's bid to halt sentencing set for Friday for his conviction on criminal charges stemming from hush money paid to a porn star.